Assignee
GENTIUM SPA
IT·6 granted patents·6 pending applications·44 citations·filing 2004–2016
Top patents by PatentIndex Score
12 records- 0193US9539277B2Defibrotide for use in prophylaxis and/or treatment of graft versus host disease (GVHD)GENTIUM SPA·Filed 2015·Granted Jan 10, 2017·9 cites·14 claims
- 0292US9867843B2Defibrotide for use in prophylaxis and/or treatment of graft versus host disease (GVHD)GENTIUM SPA·Filed 2016·Granted Jan 16, 2018·6 cites·18 claims
- 0385US7338777B2Method for determining the biological activity of defibrotideGENTIUM SPA·Filed 2004·Granted Mar 4, 2008·25 cites·17 claims
- 0483US9782429B2Formulation having mobilizing activityGENTIUM SPA·Filed 2014·Granted Oct 10, 2017·3 cites·16 claims
- 0570US7662777B2Use of sulglicotide for the treatment of mucositisGENTIUM SPA·Filed 2005·Granted Feb 16, 2010·1 cites·6 claims
- 0660US2008194506A1Oligodeoxyribonuleotides of 4000-10000 Dalton for TreatingGENTIUM SPA·Filed 2006·Application pending·0 cites
- 0760US2011092576A1Synthetic phosphodiester oligonucleotides and therapeutical uses thereofGENTIUM SPA·Filed 2009·Application pending·0 cites
- 0859US2014005256A1Formulations with anti-tumour actionGENTIUM SPA·Filed 2013·Application pending·0 cites
- 0953US2009131362A1Use of defibrotide for the inhibition of heparanaseGENTIUM SPA·Filed 2007·Application pending·0 cites
- 1051US7838506B2DNA-based aptamers for human cathepsin GGENTIUM SPA·Filed 2008·Granted Nov 23, 2010·0 cites·11 claims
- 1147US2010298413A1Use of oligotide for the treatment of renal diseasesGENTIUM SPA·Filed 2008·Application pending·0 cites
- 1239US2015196580A1Use of defibrotide for the inhibition of heparanaseGENTIUM SPA·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →